Frederick W Driscoll's Net Worth
$2.31 Million
Who is Frederick W Driscoll?
Frederick W Driscoll has an estimated net worth of $2.31 Million. This is based on reported shares across multiple companies, which include Flexion Therapeutics Inc, NOVAVAX INC, NantKwest, Inc., OXIGENE INC, Cue Biopharma, Inc., Conformis Inc, MEI Pharma, Inc., Cellectar Biosciences, Inc., Renovacor, Inc., Invivyd, Inc., GENELABS TECHNOLOGIES INC /CA, and Abpro Corp.
SEC CIK
Frederick W Driscoll's CIK is 0001129890
Past Insider Trading and Trends
2016 was Frederick W Driscoll's most active year for acquiring shares with 8 total transactions. Frederick W Driscoll's most active month to acquire stocks was the month of May. 2017 was Frederick W Driscoll's most active year for disposing of shares, totalling 5 transactions. Frederick W Driscoll's most active month to dispose stocks was the month of January. 2011 saw Frederick W Driscoll paying a total of $398,600.00 for 170,000 shares, this is the most they've acquired in one year. In 2017 Frederick W Driscoll cashed out on 69,434 shares for a total of $736,679.04, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Flexion Therapeutics Inc No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -30.68K |
$8.50 | -$260,780.00 |
0
|
Nov 19
| |||
Form 4
| +1,044.78% | 28K |
—
|
—
| 30.68K |
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
$15.45 | -$45,341.70 | 7.78K |
Scheduled
|
Mar 23
| ||
Form 4
| -30.63% | -3.43K |
$13.93 | -$431,096.04 | 7.78K |
Scheduled
|
Feb 28
| ||
Form 4
| +12.07% | 1.13K |
$9.01 | $10,217.34 | 10.53K |
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
| +11.42% | 963 |
$8.92 | $8,589.96 | 9.4K |
May 20
| |||
Form 4
| +42.13% | 2.5K |
$9.87 | $24,668.00 | 8.43K |
May 17
| |||
Form 4
| +72.80% | 2.5K |
$9.19 | $22,971.75 | 5.93K |
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +90.85% | 1.31K |
$11.91 | $15,614.01 | 2.75K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
∞
| 1.44K |
$11.91 | $17,186.13 | 1.44K |
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVAVAX INC (NVAX) Snapshot price: $11.6
VP, CFO & Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 20K |
$1.18 | $23,600.00 | 20K |
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Aug 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NantKwest, Inc. (IBRX) Snapshot price: $3.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -37.41% | -65.30K |
$10.23 | -$668,051.57 | 109.23K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +113.00% | 92.59K |
—
|
—
| 174.53K |
Jun 6
| |||
Form 4
| +50.02% | 27.32K |
—
|
—
| 81.94K |
Jun 7
| |||
Form 4
|
∞
| 54.62K |
—
|
—
| 54.62K |
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OXIGENE INC (OTLC) Snapshot price: $0.02296
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4/A
| +190.48% | 80K |
—
|
—
| 122K |
Oct 3
| |||
Form 4
| +190.48% | 80K |
—
|
—
| 122K |
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4/A
| +5.26% | 2K |
$7.31 | $14,620.00 | 40K |
May 20
| |||
Form 4
| +5.26% | 2K |
$7.31 | $14,620.00 | 40K |
May 20
| |||
| No matching records found | |||||||||
Cue Biopharma, Inc. (CUE) Snapshot price: $0.7586
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||